Quest Diagnostics Incorporated (DGX) Financials

DGX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 16.7 billion 9.0 billion
Dec. 31, 2025 16.2 billion 8.9 billion
Sept. 30, 2025 16.2 billion 8.8 billion
June 30, 2025 16.0 billion 8.6 billion

DGX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 164.0 million 20.0 million
Dec. 31, 2025 307.0 million 25.0 million
Sept. 30, 2025 419.0 million 20.0 million
June 30, 2025 436.0 million 21.0 million

DGX Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 264.0 million
Dec. 31, 2025 245.0 million
Sept. 30, 2025 259.0 million
June 30, 2025 296.0 million

DGX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 393.0 million 5.7 billion 574.0 million
Dec. 31, 2025 420.0 million 5.7 billion 537.0 million
Sept. 30, 2025 432.0 million 5.2 billion 707.0 million
June 30, 2025 319.0 million 5.2 billion 711.0 million

DGX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 112.0 million
Dec. 31, 2025 112.0 million
Sept. 30, 2025 113.0 million
June 30, 2025 113.0 million

DGX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 114.0 million - 504.0 million -
Dec. 31, 2025 158.0 million - 486.0 million -
Sept. 30, 2025 144.0 million - 501.0 million -
June 30, 2025 108.0 million - 486.0 million -

DGX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.9 billion 2.0 billion
Dec. 31, 2025 2.8 billion 1.9 billion
Sept. 30, 2025 2.8 billion 1.9 billion
June 30, 2025 2.8 billion 1.8 billion

DGX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

DGX

List: Contenders

Price: $193.67

52 week price:
162.47
213.50

Dividend Yield: 1.69%

5-year range yield:
1.65%
2.37%

Forward Dividend Yield: 1.78%

Payout Ratio: 40.49%

Payout Ratio Range:
-368.69%
78.69%

Dividend Per Share: 3.44 USD

Earnings Per Share: 9.00 USD

P/E Ratio: 21.28

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 1.3 million

Ebitda: 346.0 million

Market Capitalization: 21.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 23

DGR3: 8.27%

DGR5: 8.27%

DGR10: 9.60%

DGR20: 13.64%

Links: